Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas

Neurosurgery

Volumn 39, Issue 5, 1996, Pages 921-926

  Kyritsis, Athanassios P ^a,c   Yung, W K Alfred ^a   Jaeckle, Kurt A ^a   Bruner, Janet ^a   Gleason, Mary Jo ^a   Ictech, Sandra E ^a   Flowers, Alexandra ^b   Levin, Victor A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Astrocytoma; Chemotherapy; Glioblastoma; Glioma

Indexed keywords

HYDROXYUREA; LOMUSTINE; PROCARBAZINE; TIOGUANINE;

ANAPLASTIC CARCINOMA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER RECURRENCE; DRUG EFFICACY; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; GLIOBLASTOMA; GLIOMA; HUMANS; HYDROXYUREA; LOMUSTINE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROCARBAZINE; RETREATMENT; THIOGUANINE;

EID: 0029851979     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199611000-00006     Document Type: Article

References (17)

1. Bodell WJ, Morgan WF, Rasmussen J, Williams ME, Deen DF: Potentiation of BCNU-induced cytotoxicity in 9L cells by pretreatment with 6-thioguanine. Biochem Pharmacol 34:515-520, 1985.
2. Cairncross JG, Macdonald DR, Ramsay DA: Aggressive oligodendroglioma: A chemosensitive tumor. Neurosurgery 31:78-82, 1992.
3. Coyle T, Baptista J, Winfield J, Clark K, Poiesz B, Kirshner J, Scalzo A, Newman PN, King R, Graziano S: Mechlorethamine, vincristine, and procarbazine chemotherapy for recurrent highgrade glioma in adults: A Phase II study. J Clin Oncol 8:2014-2018, 1990.
4. Donehower RC: Hydroxyurea, in Chabner B (ed): Pharmacologic Principles of Cancer Treatment. Philadelphia, W.B. Saunders Co., 1982, pp 269-275.
5. Fujimoto S, Ogawa M, Sakurai Y: Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride. Cancer Res 42:4079-4085, 1982.
6. Hunter KJ, Deen DF, Marton LJ: Differential response to 1,3-bis(2-chloroethyl)-1-nitrosourea in drug-resistant and -sensitive 9L rat brain tumor cells pretreated with alpha-difluoromethylornithine and 6-thioguanine. Int J Cancer 44:658-660, 1989.
7. Jerermic B, Grujicic D, Jevremovic S, Stanisavljevic B, Milojevic L, Djuric L, Mijatovic L: Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: A Phase II study. J Clin Oncol 10:1074-1077, 1992.
8. Kyritsis AP: Chemotherapy for malignant gliomas. Oncology 7:93-100, 1993.
9. Levin VA: Clinical pharmacology of the nitrosoureas, in Prestayko AW, Baker LH, Crooke ST, Carter SK, Schein PS (eds): Nitrosoureas. New York, Academic Press, 1981, pp 171-180.
10. Levin VA: Chemotherapy of primary brain tumors, in Vick NA, Bigner DD (eds): Neuro-Oncology, Neurologic Clinics of North America. Philadelphia, W.B. Saunders Co., 1985, vol 3, no 4, pp 855-866.
11. Levin VA, Prados MD: Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance. J Clin Oncol 10:766-771, 1992.
12. Levin VA, Thall PF, Maor M, Yung WKA, Bruner J, Sawaya R, Kyritsis A, Leeds N, Woo S, Rodriguez L, Gleason M: Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme. Int J Radiol Biol Phys 33:357-364, 1995.
13. 6-alkylguanine-DNA alkyltransferase in vivo by pretreatment with antineoplastic agents. Biochem Pharmacol 38:929-934, 1989.
14. 6-methylguanine-DNA methyltransferase activity on chloroethylnitrosourea chemotherapy in brain tumors. Int J Cancer 55:76-81, 1993.
15. Newton HB, Junck L, Bromberg J, Page MA, Greenberg HS: Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure. Neurology 40:1743-1746, 1990.
16. Prados M, Rodriguez L, Chamberlain M, Silver P, Levin V: Treatment of recurrent gliomas with 1,3-bis(2-chloroethyl)-1-nitrosourea and alpha-difluoromethylornithine. Neurosurgery 24:806-809, 1989.
17. Weinkam RJ, Shiba DA: Metabolic activation of procarbazine. Life Sci 22:937-946, 1978.